Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates
1/3 14:15
Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $1. This compares to loss of $0.79 per share a year ago. These figures are adjusted for non-recurring items....